Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) reported Q2 EPS of ($0.56), $0.12 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Longboard Pharmaceuticals, Inc. (LBPH) click here.